These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27582282)

  • 1. Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials.
    Ibrahim NE; Gaggin HK; Konstam MA; Januzzi JL
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27582282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR;
    Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of novel biomarkers in heart failure: towards personalized medicine.
    Schmitter D; Cotter G; Voors AA
    Heart Fail Rev; 2014 May; 19(3):369-81. PubMed ID: 23709316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptide-guided management in heart failure.
    Chioncel O; Collins SP; Greene SJ; Ambrosy AP; Vaduganathan M; Macarie C; Butler J; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):556-68. PubMed ID: 27110656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbelievable Folly of Clinical Trials in Heart Failure: The Inconvenient Truth About How Investigators and Guidelines Weigh Evidence.
    Packer M
    Circ Heart Fail; 2016 Apr; 9(4):e002837. PubMed ID: 27009552
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic markers of acute decompensated heart failure: the emerging roles of cardiac biomarkers and prognostic scores.
    Cohen-Solal A; Laribi S; Ishihara S; Vergaro G; Baudet M; Logeart D; Mebazaa A; Gayat E; Vodovar N; Pascual-Figal DA; Seronde MF
    Arch Cardiovasc Dis; 2015 Jan; 108(1):64-74. PubMed ID: 25534886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.
    Morbach C; Buck T; Rost C; Peter S; Günther S; Störk S; Prettin C; Erbel R; Ertl G; Angermann CE;
    Clin Res Cardiol; 2018 Feb; 107(2):95-107. PubMed ID: 29143161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
    Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
    Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic Peptides and the Management of Heart Failure.
    Kern T; Kedan I; Kimchi A
    Rev Cardiovasc Med; 2015; 16(2):95-104. PubMed ID: 26198556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and novel biomarkers in heart failure: bench to bedside.
    Ghashghaei R; Arbit B; Maisel AS
    Curr Opin Cardiol; 2016 Mar; 31(2):191-5. PubMed ID: 26814650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the role of biomarkers in heart failure trials: expert consensus document.
    Kramer F; Sabbah HN; Januzzi JJ; Zannad F; Peter van Tintelen J; Schelbert EB; Kim RJ; Milting H; Vonk R; Neudeck B; Clark R; Witte K; Dinh W; Pieske B; Butler J; Gheorghiade M
    Heart Fail Rev; 2017 May; 22(3):263-277. PubMed ID: 28332132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of natriuretic peptides testing in heart failure - Impact of novel therapies.
    Mitoff P
    Clin Biochem; 2016 Jun; 49(9):643-644. PubMed ID: 27060498
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.
    Eapen ZJ; Tang WH; Felker GM; Hernandez AF; Mahaffey KW; Lincoff AM; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):594-600. PubMed ID: 22811505
    [No Abstract]   [Full Text] [Related]  

  • 14. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
    Francis GS; Felker GM; Tang WH
    J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges.
    Lainscak M; Anker MS; von Haehling S; Anker SD
    Herz; 2009 Dec; 34(8):589-93. PubMed ID: 20024637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.
    Dhingra R; Vasan RS
    Trends Cardiovasc Med; 2017 Feb; 27(2):123-133. PubMed ID: 27576060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in heart failure: a review of biomarkers, emerging pharmacological therapies, durable mechanical support and telemonitoring.
    Moayedi Y; Ross HJ
    Clin Sci (Lond); 2017 Apr; 131(7):553-566. PubMed ID: 28302916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers: optimizing treatment guidance in heart failure.
    Böhm M; Voors AA; Ketelslegers JM; Schirmer SH; Turgonyi E; Bramlage P; Zannad F
    Clin Res Cardiol; 2011 Nov; 100(11):973-81. PubMed ID: 21779815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and Emerging Roles of Biomarkers in Heart Failure.
    Ibrahim NE; Januzzi JL
    Circ Res; 2018 Aug; 123(5):614-629. PubMed ID: 30355136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.